Identification of 4-2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-([(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT KinaseHEERDING, Dirk A; RHODES, Nelson; YAMASHITA, Dennis S et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 18, pp 5663-5679, issn 0022-2623, 17 p.Article

Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor ActivityRHODES, Nelson; HEERDING, Dirk A; KAHANA, Jason A et al.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2366-2374, issn 0008-5472, 9 p.Article

Impact of Common Epidermal Growth Factor Receptor and HER2 Variants on Receptor Activity and Inhibition by LapatinibGILMER, Tona M; CABLE, Louann; WOOD, Edgar R et al.Cancer research (Baltimore). 2008, Vol 68, Num 2, pp 571-579, issn 0008-5472, 9 p.Article

2,3,5-Trisubstituted pyridines as selective AKT inhibitors—Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivityHONG LIN; YAMASHITA, DennisS; ZHIHONG LAI et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 2, pp 673-678, issn 0960-894X, 6 p.Article

Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolinesGAUL, Micheal D; YU GUO; MURRAY, Doris M et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 4, pp 637-640, issn 0960-894X, 4 p.Article

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancerRUSNAK, David W; AFFLECK, Karen; JOWETT, Amanda et al.Cancer research (Baltimore). 2001, Vol 61, Num 19, pp 7196-7203, issn 0008-5472Article

Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitorsSTEVENS, Kirk L; ALLIGOOD, Krystal J; KEITH, Barry R et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 1, pp 21-26, issn 0960-894X, 6 p.Article

Thienopyrimidine-based dual EGFR/ErbB-2 inhibitorsRHEAULT, Tara R; CAFERRO, Thomas R; SHEWCHUK, Lisa M et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 3, pp 817-820, issn 0960-894X, 4 p.Article

Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline seriesPETROV, Kimberly G; ZHANG, Yue-Mei; WOOD, Edgar R et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 17, pp 4686-4691, issn 0960-894X, 6 p.Article

Discovery and in vitro evaluation of potent kinase inhibitors : Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidinesALBERTI, Michael J; AUTEN, Elizabeth P; LACKEY, Karen E et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 16, pp 3778-3781, issn 0960-894X, 4 p.Article